One of the most successful and revolutionary products introduced in the last International Congress of Human Microbiome, held in Madrid on 1-2 February.

Each envelope contains 3000 million Colony Forming Units (CFU):

  • Lactococcus lactis W19
  • Lactobacillus paracasei W20
  • Lactobacillus plantarum W1
  • Lactobacillus plantarum W21
  • Lactobacillus acidophilus W22
  • Lactobacillus salivarius W24
  • Bifidobacterium lactis W51
  • Bifidobacterium lactis W52
  • Enterococcus faecium W54

20 envelopes of 3 g – 1 envelope per day taken on an empty stomach.

The latest generation symbiotic possesses own clinical studies where it has been carefully selected the most efficient bacterial strains in the reduction of pathogens such as Clostridium dificcile and Candida albicans, which are also the most efficient strains in the short-chain fatty acids production in the bowel.

The new formula, in particular, includes a new specific strain: Lactobacillus plantarum W1, which has demonstrated to be the most efficient one in the lactic acid production.

The matrix ProbioActTM consists on a specific quantitative and qualitative selection of prebiotics required for each specific strains contained in the product.

New formula also includes hydrolysed rice protein, which increases, even more, the short-chain fatty acid production by bacteria, and significantly reduces the osmotic shock suffered by the bacteria on contact with water before being consumed. It also increases the shelf-life of the product, ensuring a higher percentage of survival of bacterial strains in the gut.

It’s known that a common probiotic survival percentage is only around 1%, (the reason why these kinds of products employ huge amounts of bacteria in its composition).

Therefore, thanks to its high-survival matrix, it is only needed to supply 3 millions of CFU, where 90% of them are proved to get in the intestinal tract.

The only last generation symbiotic in the market proved by own studies (human and in vitro).

The safest bet for intestinal permeability prevention and treatment, related to the development of several chronic diseases.

If you need more information about our product, or you need a manufacturer to develop and customize your own product with this patent in its composition, please fill out the enquiry form attached to this page.